These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 11095462)
1. Postnatal elimination of transplacentally acquired disease-associated antibodies in infants born to families with type 1 diabetes. The Finnish TRIGR Study Group. Trial to Reduce IDDM in the Genetically at Risk. Hämäläinen AM; Ronkainen MS; Akerblom HK; Knip M J Clin Endocrinol Metab; 2000 Nov; 85(11):4249-53. PubMed ID: 11095462 [TBL] [Abstract][Full Text] [Related]
2. Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood. Roll U; Christie MR; Füchtenbusch M; Payton MA; Hawkes CJ; Ziegler AG Diabetes; 1996 Jul; 45(7):967-73. PubMed ID: 8666150 [TBL] [Abstract][Full Text] [Related]
3. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children. Savola K; Sabbah E; Kulmala P; Vähäsalo P; Ilonen J; Knip M Diabetologia; 1998 Nov; 41(11):1293-7. PubMed ID: 9833935 [TBL] [Abstract][Full Text] [Related]
4. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group. Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375 [TBL] [Abstract][Full Text] [Related]
5. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. Kulmala P; Savola K; Petersen JS; Vähäsalo P; Karjalainen J; Löppönen T; Dyrberg T; Akerblom HK; Knip M J Clin Invest; 1998 Jan; 101(2):327-36. PubMed ID: 9435304 [TBL] [Abstract][Full Text] [Related]
6. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. Kimpimäki T; Kulmala P; Savola K; Kupila A; Korhonen S; Simell T; Ilonen J; Simell O; Knip M J Clin Endocrinol Metab; 2002 Oct; 87(10):4572-9. PubMed ID: 12364437 [TBL] [Abstract][Full Text] [Related]
7. High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group. Seissler J; Atik Y; Klinghammer A; Scherbaum WA Horm Metab Res; 1999 Dec; 31(12):657-61. PubMed ID: 10668918 [TBL] [Abstract][Full Text] [Related]
8. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes. Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408 [TBL] [Abstract][Full Text] [Related]
9. IA-2 antibodies--a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group. Savola K; Bonifacio E; Sabbah E; Kulmala P; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Meriläinen J; Akerblom HK; Knip M Diabetologia; 1998 Apr; 41(4):424-9. PubMed ID: 9562346 [TBL] [Abstract][Full Text] [Related]
10. Environmental factors related to the induction of beta-cell autoantibodies in 1-yr-old healthy children. Wahlberg J; Fredriksson J; Nikolic E; Vaarala O; Ludvigsson J; Pediatr Diabetes; 2005 Dec; 6(4):199-205. PubMed ID: 16390388 [TBL] [Abstract][Full Text] [Related]
11. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients. Kasuga A; Maruyama T; Nakamoto S; Ozawa Y; Suzuki Y; Saruta T J Autoimmun; 1999 Mar; 12(2):131-5. PubMed ID: 10047433 [TBL] [Abstract][Full Text] [Related]
12. Disease-associated autoantibodies during pregnancy and at birth in families affected by type 1 diabetes. Hämäläinen AM; Savola K; Kulmala PK; Koskela P; Akerblom HK; Knip M; Clin Exp Immunol; 2001 Nov; 126(2):230-5. PubMed ID: 11703365 [TBL] [Abstract][Full Text] [Related]
13. Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome. Morgenthaler NG; Seissler J; Achenbach P; Glawe D; Payton M; Meinck HM; Christie MR; Scherbaum WA Autoimmunity; 1997; 25(4):203-11. PubMed ID: 9344328 [TBL] [Abstract][Full Text] [Related]
14. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease. Seissler J; de Sonnaville JJ; Morgenthaler NG; Steinbrenner H; Glawe D; Khoo-Morgenthaler UY; Lan MS; Notkins AL; Heine RJ; Scherbaum WA Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590 [TBL] [Abstract][Full Text] [Related]
15. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie. Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004 [TBL] [Abstract][Full Text] [Related]
16. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives]. Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282 [TBL] [Abstract][Full Text] [Related]
17. Islet cell antibodies represent autoimmune response against several antigens. Månsson L; Törn C; Landin-Olsson M Int J Exp Diabetes Res; 2001; 2(2):85-90. PubMed ID: 12369720 [TBL] [Abstract][Full Text] [Related]
18. Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus. Borg H; Fernlund P; Sundkvist G Clin Chem; 1997 Dec; 43(12):2358-63. PubMed ID: 9439455 [TBL] [Abstract][Full Text] [Related]
19. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes. Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878 [TBL] [Abstract][Full Text] [Related]
20. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children. Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]